Retraction
Differential modulatory effects of GSK-3b and HDM2 on sorafenib-induced AIF nuclear translocation (programmed necrosis) in melanoma
Paper Information
Record ID:
29693
Author(s):
Journal:
Publication Date:
September 19, 2011
Retraction Date:
June 15, 2021
(4.4 years years ago)
Subjects:
Institutions:
Countries:
Article Type:
Publisher:
Springer - Biomed Central (BMC)
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Retraction Details
Retraction Reasons:
Nature of Retraction:
Retraction
Retraction Notice:
10.1186/s12943-021-01378-8Additional Notes:
David Panka has ORI finding of misconduct, see: https://ori.hhs.gov/content/case-summary-panka-david
Citations (12)
12
Total Citations0
Post-Retraction11
Pre-Retraction0
Same DayHeavy Metals Removal Using Carbon Based Nanocomposites
Unknown Authors
Unknown Journal
Published: Unknown
Corilagin inhibits breast cancer growth via reactive oxygen species‐dependent apoptosis and autophagy
Yinping Tong, Gongye Zhang, Li Yang et al. (8 authors)
Journal of Cellular and Molecular Medicine
Open Access
Published: Jun 2018
54 citations
54 citations
1092 days before retraction
Annonaceous acetogenin mimic AA005 suppresses human colon cancer cell growth in vivo through downregulation of Mcl-1
Bing Han, Yuxia Cao, Zhanming Li et al. (8 authors)
Acta Pharmacologica Sinica
Open Access
Published: Jun 2018
11 citations
11 citations
1092 days before retraction
Antiangiogenic antibody improves melanoma detection by fluorescently labeled therapeutic antibodies
Larissa Sweeny, Andrew C. Prince, Neel Patel et al. (7 authors)
The Laryngoscope
Open Access
Published: Aug 2016
10 citations
10 citations
1749 days before retraction
Ascorbic Acid Induces Necrosis in Human Laryngeal Squamous Cell Carcinoma via ROS, PKC, and Calcium Signaling
Minwoo Baek, Heui‐Seung Cho, Sun‐Hun Kim et al. (5 authors)
Journal of Cellular Physiology
Published: May 2016
38 citations
38 citations
1848 days before retraction
Pristimerin triggers AIF-dependent programmed necrosis in glioma cells via activation of JNK
Hongwei Zhao, Chen Wang, Bin Lü et al. (13 authors)
Cancer Letters
Published: Feb 2016
51 citations
51 citations
1943 days before retraction
Paper citing Differential modulatory effects of GSK-3b and HDM2...
Unknown Authors
Unknown Journal
Published: Jul 2015
2149 days before retraction
Targeting the Cell Cycle and p53 in Combination with BRAF-Directed Therapy
Dale Han, Keiran S.M. Smalley
Cancer drug discovery and develogment/Cancer drug discovery and development
Published: Nov 2014
2394 days before retraction
Paper citing Differential modulatory effects of GSK-3b and HDM2...
Unknown Authors
Unknown Journal
Published: Jun 2014
2571 days before retraction
β-Lapachone induces programmed necrosis through the RIP1-PARP-AIF-dependent pathway in human hepatocellular carcinoma SK-Hep1 cells
E J Park, K-j Min, T-J Lee et al. (6 authors)
Cell Death and Disease
Open Access
Published: May 2014
96 citations
96 citations
2588 days before retraction
<scp>ABT</scp>‐263 enhances sorafenib‐induced apoptosis associated with <scp>A</scp>kt activity and the expression of <scp>B</scp>ax and p21<sup>(</sup><scp><sup>CIP1/WAF1</sup></scp><sup>)</sup> in human cancer cells
Jingru Li, Yicheng Chen, Jiali Wan et al. (6 authors)
British Journal of Pharmacology
Open Access
Published: Feb 2014
26 citations
26 citations
2666 days before retraction
Glycogen Synthase Kinase 3 as an Anticancer Drug Target: Novel Experimental Findings and Trends in the Design of Inhibitors
Dmitry I. Osolodkin, Vladimir A. Palyulin, Н. С. Зефиров
Current Pharmaceutical Design
Published: Dec 2012
25 citations
25 citations
3099 days before retraction
Quick Stats
Total Citations:
12
Years Since Retraction:
4.4 years
Open Access:
Yes
Last Checked:
Jul 24, 2025